BeStock  
Stocks › Biotechnology › ANL

Adlai Nortye Group ANL

US equityMarket cap rank #3302Biotechnology
$14.05 −$0.41 (-2.84%)
Pre-market · Oct 8, 8:40 am ET · After hours $14.05 0.00%
Open$14.41
Prev close$14.46
Day range$14.03 – $15.04
Volume95.1K
Market cap$904.79M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-21.3x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average -3.6x

Price / book4.2x
CheapRich

Near the top of its 5-year range · 86th percentile, 5-year average -3.5x

#4101 of 5317 stocks by PB (1 = cheapest)

Price / sales50.1x
CheapRich

Above its usual level · 76th percentile, 5-year average 36.1x

#4839 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-26x-17x-7x3xAug '23Mar '25Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$11.24
Price vs. fair value+25.0%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.21 – -3.49 86% (pricier than usual) #4101 of 5317 (1 = cheapest)
PE -21.29 -31.31 -3.64 2% (cheaper than usual) –
PS 50.11 72.87 36.11 76% (pricier than usual) #4839 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$11.24
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on ANL.

Leave a comment

Scroll to Top